APA

Urbanova J., Andel M., Potockova J., Klima J., Macek J., Ptacek P., Mat'oska V., Kumstyrova T. & Heneberg P. (20160923). Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. : Current pharmaceutical design.

Chicago

Urbanova Jana, Andel Michal, Potockova Jana, Klima Josef, Macek Jan, Ptacek Pavel, Mat'oska Vaclav, Kumstyrova Tereza and Heneberg Petr. 20160923. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. : Current pharmaceutical design.

Harvard

Urbanova J., Andel M., Potockova J., Klima J., Macek J., Ptacek P., Mat'oska V., Kumstyrova T. and Heneberg P. (20160923). Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. : Current pharmaceutical design.

MLA

Urbanova Jana, Andel Michal, Potockova Jana, Klima Josef, Macek Jan, Ptacek Pavel, Mat'oska Vaclav, Kumstyrova Tereza and Heneberg Petr. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. : Current pharmaceutical design. 20160923.